Imperial Innovations, AbbVie Ventures and Merck Ventures are among the backers of the Cancer Research UK spinout that is working on cancer therapies.

Existing backer WuXi Pharmatech Healthcare Fund returned for a series B round that will enable Tennor to move its antibiotics into late-stage development.

Relay Therapeutics emerged last week with $57m in funding to support the development of cancer therapies based on a new understanding of how protein molecules undergo changes.

The ophthalmic disease treatment developer has closed its series A round, which included Boehringer Ingelheim's corporate venturing unit.

Eyevensys, based on reserach conducted at Paris Descartes University, closes its series A round at $10m three years after it raised the initial tranche.

DE Shaw Research has backed a series A round for Relay Therapeutics, launched yesterday to commercialise research from Shaw and a range of universities.

Glooko has merged with its peer Diasend and raised $8m in funding in the process in a round featuring existing shareholder Samsung.

DE Shaw Research has backed a series A round for Relay Therapeutics, launched yesterday to commercialise research from Shaw and a range of universities.